Tower Research Capital (TRC)’s Firefly Neuroscience AIFF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-5,926
Closed -$7.17K – 6252
2026
Q2
$7.17K Buy
5,926
+3,194
+117% +$5.56K ﹤0.01% 4147
2026
Q1
$5.96K Buy
2,732
+70
+3% +$87 ﹤0.01% 4087
2025
Q4
$2.33K Buy
2,662
+446
+20% +$832 ﹤0.01% 4551
2025
Q3
$6.45K Sell
2,216
-860
-28% -$2.44K ﹤0.01% 4160
2025
Q2
$8.7K Buy
3,076
+1,567
+104% +$4.97K ﹤0.01% 4012
2025
Q1
$5.93K Sell
1,509
-281
-16% -$1.29K ﹤0.01% 4078
2024
Q4
$4.74K Buy
1,790
+486
+37% +$1.51K ﹤0.01% 4405
2024
Q3
$3.96K Buy
1,304
+257
+25% +$1.35K ﹤0.01% 4720
2024
Q2
$6.5K Buy
1,047
+571
+120% +$4.25K ﹤0.01% 4571
2024
Q1
$4.94K Sell
476
-1,777
-79% -$11.9K ﹤0.01% 4610
2023
Q4
$11.4K Buy
2,253
+1,991
+760% +$12.9K ﹤0.01% 4132
2023
Q3
$2.04K Hold
262
– – ﹤0.01% 5226
2023
Q2
$2.4K Sell
262
-3
-1% -$34 ﹤0.01% 5206
2023
Q1
$2K Buy
265
+3
+1% +$59 ﹤0.01% 5418
2022
Q4
$4K Sell
262
-40
-13% -$931 ﹤0.01% 5088
2022
Q3
$8K Buy
302
+147
+95% +$5.39K ﹤0.01% 4822
2022
Q2
$6K Sell
155
-132
-46% -$12.7K ﹤0.01% 4968
2022
Q1
$46K Buy
+287
New +$38.8K ﹤0.01% 2811

Other funds holding AIFF

Tower Research Capital (TRC)'s AIFF Position: Q3 2026 in Review

Tower Research Capital (TRC) sold out of Firefly Neuroscience (AIFF) in Q3 2026, closing a stake of 5,926 shares — an estimated $7.17K sold.

Tower Research Capital (TRC) first reported a position in AIFF in Q1 2022 and held it in 18 quarters. The position peaked at $46K in Q1 2022. 21 funds tracked by Wall St. Rank hold AIFF as of Q3 2026.

  • Tower Research Capital (TRC) reported no remaining Firefly Neuroscience position as of Q3 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 5,926 Firefly Neuroscience shares in Q3 2026, an estimated $7.17K.
  • Tower Research Capital (TRC) first reported a position in Firefly Neuroscience in Q1 2022 and held it in 18 quarters.
  • Tower Research Capital (TRC)'s Firefly Neuroscience position peaked at $46K in Q1 2022.
  • 21 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q3 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.